2,383
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Loss of CENPF leads to developmental failure in mouse embryos

, , , , & ORCID Icon
Pages 2784-2799 | Received 20 Mar 2019, Accepted 21 Aug 2019, Published online: 03 Sep 2019

References

  • Cleveland DW, Mao Y, Sullivan KF. Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell. 2003;112:407–421.
  • Giunta S, Funabiki H Integrity of the human centromere DNA repeats is protected by CENP-A, CENP-C, and CENP-T. Proc Natl Acad Sci USA 2017; 114:1928–1933.
  • Wan X, O’Quinn RP, Pierce HL, et al. Protein architecture of the human kinetochore microtubule attachment site. Cell. 2009;137:672–684.
  • Karpen GH, Allshire RC. The case for epigenetic effects on centromere identity and function. Trends Genet. 1997;13:489–496.
  • Walczak CE, Cai S, Khodjakov A. Mechanisms of chromosome behaviour during mitosis. Nat Rev Mol Cell Biol. 2010;11:91–102.
  • Liao H, Winkfein RJ, Mack G, et al. CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J Cell Biol. 1995;130:507–518.
  • Holt SV, Vergnolle MA, Hussein D, et al. Silencing Cenp-F weakens centromeric cohesion, prevents chromosome alignment and activates the spindle checkpoint. J Cell Sci. 2005;118:4889–4900.
  • Welner S, Trier NH, Frisch M, et al. Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay. Mol Cancer. 2013;12:95.
  • Zhu X. Structural requirements and dynamics of mitosin-kinetochore interaction in M phase. Mol Cell Biol. 1999;19:1016–1024.
  • Berto A, Doye V. Regulation of Cenp-F localization to nuclear pores and kinetochores. Cell Cycle. 2018;17:2122–2133.
  • Rattner JB, Rao A, Fritzler MJ, et al. CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cell Motility Cytoskeleton. 1993;26:214–226.
  • Loftus KM, Cui H, Coutavas E, King DS, Ceravolo A, Pereiras D, Solmaz SR. Mechanism for G2 phase-specific nuclear export of the kinetochore protein CENP-F. Cell Cycle. 2017;16:1414–1429.
  • Hussein D, Taylor SS. Farnesylation of Cenp-F is required for G2/M progression and degradation after mitosis. J Cell Sci. 2002;115:3403–3414.
  • Laoukili J, Kooistra MR, Bras A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005;7:126–136.
  • Yang Z, Guo J, Chen Q, et al. Silencing mitosin induces misaligned chromosomes, premature chromosome decondensation before anaphase onset, and mitotic cell death. Mol Cell Biol. 2005;25:4062–4074.
  • Bomont P, Maddox P, Shah JV, et al. Unstable microtubule capture at kinetochores depleted of the centromere-associated protein CENP-F. Embo J. 2005;24:3927–3939.
  • Dai Y, Liu L, Zeng T, et al. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma. Biochem Biophys Res Commun. 2013;436:711–718.
  • Serio G, Margaria V, Jensen S, et al. Small GTPase Rab5 participates in chromosome congression and regulates localization of the centromere-associated protein CENP-F to kinetochores. Proc Natl Acad Sci USA 2011; 108:17337–17342.
  • Ma R, Hou X, Zhang L, et al. Rab5a is required for spindle length control and kinetochore-microtubule attachment during meiosis in oocytes. Faseb J. 2014;28:4026–4035.
  • Xiao B, Verma SC, Cai Q, et al. Bub1 and CENP-F can contribute to Kaposi’s sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores. J Virol. 2010;84:9718–9732.
  • Gurden MD, Holland AJ, van Zon W, Tighe A, Vergnolle MA, Andres DA, Spielmann HP, Malumbres M, Wolthuis RM, Cleveland DW, et al. Cdc20 is required for the post-anaphase, KEN-dependent degradation of centromere protein F. J Cell Sci. 2010;123:321–330.
  • Ciossani G, Overlack K, Petrovic A, et al. The kinetochore proteins CENP-E and CENP-F directly and specifically interact with distinct BUB mitotic checkpoint Ser/Thr kinases. J Biol Chem. 2018;293:10084–10101.
  • Feng J, Huang H, Yen TJ. CENP-F is a novel microtubule-binding protein that is essential for kinetochore attachments and affects the duration of the mitotic checkpoint delay. Chromosoma. 2006;115:320–329.
  • Ueda S, Kondoh N, Tsuda H, et al. Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer. BMC Cancer. 2008;8:384.
  • Brown HK, Ottewell PD, Coleman RE, et al. The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells. J Cell Mol Med. 2011;15:501–513.
  • Clark GM, Allred DC, Hilsenbeck SG, et al. Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer. Cancer Res. 1997;57:5505–5508.
  • Kim HE, Kim DG, Lee KJ, et al. Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas. PloS One. 2012;7:e43223.
  • Mi YJ, Gao J, Xie JD, et al. Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma. Dis Esophagus. 2013;26:636–643.
  • Toralova T, Susor A, Nemcova L, et al. Silencing CENPF in bovine preimplantation embryo induces arrest at 8-cell stage. Reproduction. 2009;138:783–791.
  • Lu A, Zhou CJ, Wang DH, et al. Cytoskeleton-associated protein 5 and clathrin heavy chain binding regulates spindle assembly in mouse oocytes. Oncotarget. 2017;8:17491–17503.
  • Clift D, McEwan WA, Labzin LI, et al. A Method for the Acute and Rapid Degradation of Endogenous Proteins. Cell. 2017;171:1692–706 e18.
  • Clift D, So C, McEwan WA, et al. Acute and rapid degradation of endogenous proteins by Trim-Away. Nat Protoc. 2018;13:2149–2175.
  • Pfaltzgraff ER, Roth GM, Miller PM, et al. Loss of CENP-F results in distinct microtubule-related defects without chromosomal abnormalities. Mol Biol Cell. 2016;27:1990–1999.
  • Manalo A, Schroer AK, Fenix AM, et al. Loss of CENP-F Results in Dilated Cardiomyopathy with Severe Disruption of Cardiac Myocyte Architecture. Sci Rep. 2018;8:7546.
  • Shigeishi H, Mizuta K, Higashikawa K, et al. Correlation of CENP-F gene expression with tumor-proliferating activity in human salivary gland tumors. Oral Oncol. 2005;41:716–722.
  • Kanfer G, Courtheoux T, Peterka M, et al. Mitotic redistribution of the mitochondrial network by Miro and Cenp-F. Nat Commun. 2015;6:8015.
  • Schafer-Hales K, Iaconelli J, Snyder JP, et al. Farnesyl transferase inhibitors impair chromosomal maintenance in cell lines and human tumors by compromising CENP-E and CENP-F function. Mol Cancer Ther. 2007;6:1317–1328.
  • Moudgil DK, Westcott N, Famulski JK, et al. A novel role of farnesylation in targeting a mitotic checkpoint protein, human Spindly, to kinetochores. J Cell Biol. 2015;208:881–896.
  • Wright LP, Philips MR. Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J Lipid Res. 2006;47:883–891.
  • Crespo NC, Ohkanda J, Yen TJ, et al. The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells. J Biol Chem. 2001;276:16161–16167.
  • Ashar HR, James L, Gray K, et al. Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules. J Biol Chem. 2000;275:30451–30457.
  • Verstraeten VL, Peckham LA, Olive M, et al. Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect. Proc Natl Acad Sci U S A. 2011;108:4997–5002.
  • Oh SH, Kang JH, Kyu Woo J, et al. A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer. Int J Cancer. 2012;131:537–547.
  • Wang E, Casciano CN, Clement RP, Johnson WW. The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein. Cancer Res. 2001;61:7525–7529.
  • Smalley KS, Eisen TG. Farnesyl transferase inhibitor SCH66336 is cytostatic, pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells. Int J Cancer. 2003;105:165–175.
  • Kanfer G, Peterka M, Arzhanik VK, et al. CENP-F couples cargo to growing and shortening microtubule ends. Mol Biol Cell. 2017;28:2400–2409.
  • Liu JH, Zhu JQ, Liang XW, et al. Diploid parthenogenetic embryos adopt a maternal-type methylation pattern on both sets of maternal chromosomes. Genomics. 2008;91:121–128.
  • Peng M, Li Y, Huang H, et al. The expression of GCN5, HDAC1 and DNMT1 in parthenogenetically activated mouse embryos. J Obstet Gynaecol. 2015;35:131–135.
  • Gao W, Yu X, Hao J, et al. Ascorbic acid improves parthenogenetic embryo development through TET proteins in mice. In: Bioscience reports. London: Portland Press; 2019. p. 39.
  • Rodriguez-Terrones D, Gaume X, Ishiuchi T, Weiss A, Kopp A, Kruse K, Penning A, Vaquerizas JM, Brino L, Torres-Padilla ME. A molecular roadmap for the emergence of early-embryonic-like cells in culture. Nat Genet. 2018;50:106–119.
  • Wang J, Wang L, Feng G, et al. Asymmetric Expression of LincGET Biases Cell Fate in Two-Cell Mouse Embryos. Cell. 2018;175:1887–901 e18.
  • Hupalowska A, Jedrusik A, Zhu M, et al. CARM1 and Paraspeckles Regulate Pre-implantation Mouse Embryo Development. Cell. 2018;175:1902–16 e13.
  • Mehlmann LM, Uliasz TF, Lowther KM. SNAP23 is required for constitutive and regulated exocytosis in mouse oocytes. Biol Reprod. 2019;101:338–346.
  • Chen X, Liu M, Lou H, et al. Degradation of endogenous proteins and generation of a null-like phenotype in zebrafish using Trim-Away technology. Genome Biol. 2019;20:19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.